Improvements to the present TNM staging system may be achieved by the inclusion of proven nonanatomic prognostic factors independent of tumor extent, lymph node status, and the presence or absence of metastasis. See also pages 2436–46.
No takes yet. Share an insight, caveat, or question.
Hermanek et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: